Translational Research Center in Lung Cancer Disparities (TRACER) Project 2 (TRACER)
Biological Pathways in Stress Reactivity and Nicotine Addiction Among African American and White Smokers
The purpose of this study is to examine racial differences in smoking behaviors and stress responses between African American and white male smokers.
Study Overview
Status
Status
Conditions
Conditions
Detailed Description
Cigarette smoking is a leading cause of morbidity and mortality from lung cancer among adults in the US. Stress relief and smoking cessation is the best preventive strategy for reducing lung cancer risk and addressing racial disparities in outcomes. Despite this, racial differences are found among those that make quit attempts. Stress has been found to be related to smoking initiation, maintenance, and relapse. Yet, differences in stress responses have not been examined between African American and white smokers. Therefore, this study will examine racial differences in stress responses and smoking behaviors between African American and white male smokers
Study Type
Study Type
Enrollment (Actual)
Enrollment
Contacts and Locations
Study Locations
-
-
California
-
Los Angeles, California, United States, 90089
- University of Southern California
-
-
South Carolina
-
Charleston, South Carolina, United States, 29425
- Medical University of South Carolina
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
African American and white male daily smokers who are between the ages of 18-75 and who smoke at least 5 to 10 cigarettes per day.
Description
Inclusion Criteria:
- African American and white males
- Between the ages of 18-75 years old
- Smoke at least 5 to 10 cigarettes per day
Exclusion Criteria:
- Smokers who have a serious cognitive disorder
- Have a personal history of lung cancer
- Personal history of usage of illicit drug and alcohol abuse
- Enrollment in a smoking cessation treatment program during the past 6 months
- Current use of a nicotine replacement therapy
- Have any positive responses on the Mini International Neuropsychiatric Interview (MINI) screener
Study Plan
How is the study designed?
Design Details
- Observational Models: COHORT
- Time Perspectives: PROSPECTIVE
Number of groups / cohorts
Cohorts and Interventions
Group / CohortGroup / Cohort |
|---|
|
Baseline Health survey and Trier Social Stress Test (TSST) African American Men
African American male smokers |
|
Baseline Health survey and Trier Social Stress Test (TSST) White Men
White male smokers |
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Examining Racial Differences in Cortisol During TSST Which Activates Acute Stress Responses
Time Frame: 90-minute laboratory stress test, scheduled after completion of baseline health survey
|
Examine racial differences in acute stress responses using a validated psychological stress challenge called the Trier Social Stress Test (TSST). This aim will examine racial disparities in cortisol responses to an acute stressor among AA/Black and white male smokers in a laboratory setting. Changes in cortisol levels will be the primary outcome variable and will be measured multiple times during the course of the TSST. To examine the effects of race on acute stress responses to the TSST laboratory stressors the response area under the curve (rAUC) for cortisol will be calculated using trapezoidal approximation with the samples obtained at time zero (T0) to the last measurement (T24m). |
90-minute laboratory stress test, scheduled after completion of baseline health survey
|
|
Examining Changes in Daily Cortisol Patterns According to Race for Those Who Completed TSST.
Time Frame: 4- week and 8-week at-home post-TSST home post TSST daily saliva (cortisol) data collection
|
Examine racial differences in daily diurnal cortisol slopes to evaluate hypothalamic-pituitary-adrenal-axis dysregulation and acute stress. A higher score means a flatter slope, and reflects higher chronic stress. No scale for slope. |
4- week and 8-week at-home post-TSST home post TSST daily saliva (cortisol) data collection
|
|
Examine the Relationship Between Perceived Stress and Smoking Behavior Across Groups
Time Frame: Baseline health survey pre-TSST
|
Assessed perceived stress using the 4-item Perceived Stress Scale (PSS-4), a validated self-report measure of how stressful an individual's life situations are perceived to be. Participants rate each item on a 5-point scale from 0 (never) to 4 (very often). Positively worded items are reverse-scored, and the four items are summed to produce a total score ranging from 0 to 16. Higher scores indicate greater perceived stress. Stress is compared for those who reported at least 1 quit attempt within the past 12 months and for those who did not. |
Baseline health survey pre-TSST
|
Collaborators and Investigators
Sponsor
Sponsor
Collaborators
Collaborators
Investigators
Investigators
- Principal Investigator: Vanessa Sheppard, PhD, Virginia Commonwealth University
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- MCC-21-18891
- 00116801 (Other Identifier: Medical University of South Carolina)
- HM20022956 (Other Identifier: Virginia Commonwealth University)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.